Literature DB >> 9006291

Heterogeneous aortic response to acute beta-adrenergic blockade in Marfan syndrome.

A Haouzi1, H Berglund, P C Pelikan, G Maurer, R J Siegel.   

Abstract

Although prophylactic treatment with beta-blockers is used to retard aortic root dilatation in Marfan syndrome, it is not effective in all patients. To assess the effects of beta-adrenergic blockade on the aorta's elastic properties, aortic stiffness index and distensibility were calculated in 13 patients with Marfan syndrome and 10 control subjects before and after beta-adrenergic blockade. At baseline, patients with Marfan syndrome had a significantly increased stiffness index and decreased distensibility. After beta-adrenergic blockade, 8 patients with Marfan syndrome developed stiffness indexes and distensibility values that were closer to normal, whereas these variables deteriorated in 5 patients. Thus the benefit of beta-adrenergic blockade in Marfan syndrome may be the reduction in pulse pressure and myocardial contractility and also promotion of the elastic properties of the aorta. Moreover, the differential responses of aortic mechanics (normalizing or worsening) to beta-adrenergic blockade may possibly have implications for the prognosis in these patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9006291     DOI: 10.1016/s0002-8703(97)70248-5

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  11 in total

Review 1.  Management of Marfan syndrome.

Authors:  John C S Dean
Journal:  Heart       Date:  2002-07       Impact factor: 5.994

Review 2.  Marfan syndrome. Part 2: treatment and management of patients.

Authors:  Victoria Cañadas; Isidre Vilacosta; Isidoro Bruna; Valentin Fuster
Journal:  Nat Rev Cardiol       Date:  2010-03-30       Impact factor: 32.419

Review 3.  Marfan's syndrome and the heart.

Authors:  Alan Graham Stuart; Andrew Williams
Journal:  Arch Dis Child       Date:  2007-04       Impact factor: 3.791

Review 4.  Large ascending aortic aneurysm and severe aortic regurgitation in a 7-year-old child with Marfan syndrome and a review of the literature. Marfan syndrome in childhood.

Authors:  Mehmet Yazici; Serdar Soydinç; Vedat Davutoğlu; Ilyas Akdemir; M Hakan Dinçkal
Journal:  Int J Cardiovasc Imaging       Date:  2004-08       Impact factor: 2.357

5.  Arterial stiffness in the young: assessment, determinants, and implications.

Authors:  Yiu-Fai Cheung
Journal:  Korean Circ J       Date:  2010-04-22       Impact factor: 3.243

6.  Aortic pressure-area relation in Marfan patients with and without beta blocking agents: a new non-invasive approach.

Authors:  G J Nollen; B E Westerhof; M Groenink; A Osnabrugge; E E van der Wall; B J M Mulder
Journal:  Heart       Date:  2004-03       Impact factor: 5.994

7.  Influence of beta-blocker therapy on aortic blood flow in patients with bicuspid aortic valve.

Authors:  Bradley D Allen; Michael Markl; Alex J Barker; Pim van Ooij; James C Carr; S Chris Malaisrie; Patrick McCarthy; Robert O Bonow; Preeti Kansal
Journal:  Int J Cardiovasc Imaging       Date:  2016-01-27       Impact factor: 2.357

8.  Influence of Aortic Stiffness on Aortic-Root Growth Rate and Outcome in Patients With the Marfan Syndrome.

Authors:  Elif Seda Selamet Tierney; Jami C Levine; Lynn A Sleeper; Mary J Roman; Timothy J Bradley; Steven D Colan; Shan Chen; M Jay Campbell; Meryl S Cohen; Julie De Backer; Haleh Heydarian; Arvind Hoskoppal; Wyman W Lai; Aimee Liou; Edward Marcus; Arni Nutting; Aaron K Olson; David A Parra; Gail D Pearson; Mary Ella Pierpont; Beth F Printz; Reed E Pyeritz; William Ravekes; Angela M Sharkey; Shubhika Srivastava; Luciana Young; Ronald V Lacro
Journal:  Am J Cardiol       Date:  2018-02-13       Impact factor: 2.778

9.  In vivo characterization of doxycycline-mediated protection of aortic function and structure in a mouse model of Marfan syndrome-associated aortic aneurysm.

Authors:  Jason Z Cui; Ling Lee; Xiaoye Sheng; Fanny Chu; Christine P Gibson; Taline Aydinian; David C Walker; George G S Sandor; Pascal Bernatchez; Glen F Tibbits; Cornelis van Breemen; Mitra Esfandiarei
Journal:  Sci Rep       Date:  2019-02-14       Impact factor: 4.379

10.  A prospective, randomized, placebo-controlled, double-blind, multicenter study of the effects of irbesartan on aortic dilatation in Marfan syndrome (AIMS trial): study protocol.

Authors:  Michael J Mullen; Marcus D Flather; Xu Yu Jin; William G Newman; Guliz Erdem; David Gaze; Oswaldo Valencia; Winston Banya; Claire E Foley; Anne Child
Journal:  Trials       Date:  2013-12-01       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.